摘要:
The invention relates to compounds of the formula (I) in which: A is a bond, an oxygen atom, or a -0-CH 2 - group; Ar 1 is a phenyl or heteroaryl group; Ar 2 is a phenyl, heteroaryl or heterocycloalkyl group; R 1a,b,c and R 2a,b,c are a hydrogen or halogen atom or an alkyl, cycloalkyl, -alkyl-cycloalkyl group optionally substituted by one or more halogen atoms, -OR 5 (hydroxy ou alkoxy), hydroxy- alkyl, alkoxy-alkyl, alkoxy-alkoxy, halogenoalkyl, -O-halogenoalkyl, oxo, -CO- alkyl, -CO-alkyl-NR6R7, -CO-halogenoalkyl, -COOR5, alkyl-COOR5, -O-alkyl- COOR 5, -SO 2 -alkyl, -SO 2 -cycloalkyl, -SO 2 -alkyl-cycloalkyl, -SO 2 -alkyl-OR 5 , -SO 2 - alkyl-COOR 5, -SO 2 -alkyl-NR 6 R 7 -S0 2 -halogenoalkyl, alkyl-S0 2 -alkyl, -SO 2 -NR 6 R 7, - SO 2 -alkyl-O-alkyl-OR 5 , -CONR 6 R 7 , -alkyl-CONR 6 R 7 or -O-alkyl-NR 6 R 7 , or R 1a R 1b , R 1c are respectively bonded to R 2a, R 2b, R 2c and to the carbon atom bearing them and represent -O-alkyl-0-; R 3 is a hydrogen atom or an alkyl group; R 4 is a hydrogen or halogen atom or a cyano group, -OR 5, hydroxy-alkyl, -COOR 5 , -NR 6 R 7 , -CONR 6 R 7, -SO 2 -alkyl or -SO 2 -NR 6 R 7 , -NR 6 - COOR 5 , -NR 6 -COR 5, -CO-NR 6 -alkyl-OR 5 ;; R 5 , R 6 and R 7 are a hydrogen atom, an alkyl or –alkyl-phenyl group; and R 8 is a hydrogen atom, a -SO 2 -alkyl group or a group of the formula –B-Het in which B can be absent or represents a bond, an oxygen atom or a -CO- ou -SO 2 - (CH 2 )n group with n equal to 0, 1 or 2, and Het is a heteroaryl or heterocycloalkyl optionally substituted by alkyl, -SO 2 -alkyl and - COOR 5 groups. The invention also relates to a method for making the same and to the therapeutic application thereof.
摘要:
The present invention relates to the orexin receptor antagonists of the general formula (I), which are selective to orexin I receptors. (I) -wherein Ar stands for phenyl group or a 5- or 6-membered heterocyclic ring containing 1-3 identical or different heteroatoms or methylenedioxyphenyl group -these groups may optionally be substituted with one or more identical or different C1.4 alkyl group, halogen atom, hydroxyl group, C1-4 alkoxy group, trihalogenomethyl group, NHC1.4 alkyl, -N(CI-4 alkyl)2 or -NHC(=0)-C1-4 alkyl group,
摘要:
The invention relates to compounds of formula (I) wherein: E is a grouping (i) of formula -NT-CO-O- or -NT-CX-NT'- wherein X is =O or =S and T and T', that can be identical or different and selected independently, from H or an alkyl group, or (ii) forming a five-membered or six-membered ring bound in position 5 or 6 of the indazole nucleus by -NT- or by the nitrogen atom N1; R1 is at least one substituent selected independently when there are several, and being a halogen atom, an alkyl, alkenyl, alkynyl, halogenoalkyl, halogenoalcoxy, aryl, heteroaryl, heterocycloalkyl, cycloalkyl, CN, NRR', OR, NO2, COOR, CONRR', or NRCOR' group; R2 is a hydrogen atom, or an alkyl, alkenyl or alkynyl group; R3 is at least one substituent selected independently when there are several, and being a hydrogen atom, an alkyl, alkenyl, alkynyl, halogenoalcoxy, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, CN, NRR', CF3, OR, NO2, COOR, CONRR', or NRCOR' group; R4 is a hydrogen atom or a halogen atom, an alkyl, alkenyl, alkynyl, aryl, heteroaryl, heterocycloalkyl, -NR-CO-R', COOR, NRR', CHO, or CONR(OR') group; R and R' are identical or different and are independently a hydrogen atom, or an alkyl, aryl, heterocycloalkyl, cycloalkyl or heteroaryl group; and n1 is a whole number between 0 and 5, and n3 is a whole number between 0 and 3.
摘要:
The present invention relates to the orexin receptor antagonists of the general formula (I), which are selective to orexin I receptors. (I) -wherein Ar stands for phenyl group or a 5- or 6-membered heterocyclic ring containing 1-3 identical or different heteroatoms or methylenedioxyphenyl group -these groups may optionally be substituted with one or more identical or different C1.4 alkyl group, halogen atom, hydroxyl group, C1-4 alkoxy group, trihalogenomethyl group, NHC1.4 alkyl, -N(CI-4 alkyl)2 or -NHC(=0)-C1-4 alkyl group,
摘要:
The present invention relates to the orexin receptor antagonists compounds of the general formula (I) as well as to their isomers, salts and solvates, to the pharmaceutical compositions containing them and to the therapeutic application thereof.
摘要:
The invention relates to compounds of the formula (I), wherein the residues R, M, W, X, A, B, D, and Y have the stated meanings, and the physiologically compatible salts thereof. The compounds are suitable, for example, for the treatment of the metabolic syndrome, insulin resistance, obesity, and diabetes.
摘要:
The present invention relates to the orexin receptor antagonists compounds of the general formula (I) as well as to their isomers, salts and solvates, to the pharmaceutical compositions containing them and to the therapeutic application thereof.
摘要:
The invention concerns compounds corresponding to formula (I) in which R1a, R1b, R1c, R1d, R2a, R2b, R2c, R2d, R3a, R3b, R4, n, i, j, o, p, q, r and X are as defined in the description. Preparation method and therapeutic use.